Home / Compliance actions / 413797

FDA Warning Letter — Manhattan Reproductive Medicine, PC

Case 413797 — FEI 3004753417

The FDA took a Warning Letter action against Manhattan Reproductive Medicine, PC on November 20, 2013 (New York, NY). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Manhattan Reproductive Medicine, PC
Date
November 20, 2013
Fiscal Year
2014
Product Type
Biologics
Center
CBER
Location
New York, NY (United States)

Facility

Recent inspections

  • 1240497 (NAI Fri May 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1173216 (NAI Wed Jun 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117589 (VAI Wed Feb 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895464 (OAI Thu Sep 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 842598 (OAI Wed Jul 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources